Menu Back to Combination-Products-Conference

Overview

Conference: February 24-25

DIA is offering both a live in-person conference or an On Demand Library for the Combination Products Conference that allows you to view all the session recordings from the comfort of your own home/office at your own pace. Upon registration, please indicate via the check box which avenue you are registering for: in-person or on demand.

Social distancing measures may be in place at the time of the event. Therefore, we encourage you to register and make your housing arrangements early due to potential limited capacity. If the capacity limit is reached, we will only be able to offer the on demand option. Don’t miss out on your chance to meet live again with your friends and colleagues!

DIA’s Combination Products Conference is a premier forum where industry and regulators dialog on today’s best answers to key questions:

  • How can new and emerging regulatory tools be used to best advance combination product development and approval?
  • How can the regulatory framework for combination products be continuously improved?
  • How can new technologies and novel approaches be used to realize opportunities in the developmental of new therapies to meet patient needs?

Whether you are new to the field of combination products or are a seasoned veteran, there is something for everyone to take away for their own learning or back to their organization for further dissemination and sharing of information.

We are thrilled to able to offer flexibility to our attendees to attend in-person or later in a self-paced On Demand format. Please note, we are also offering flexibility to our speakers so you will experience some speakers presenting in-person and others remotely.


Program Committee

  • James  Wabby, MHS
    James Wabby, MHS Global Head, Regulatory Affairs , Emerging Technologies and Combination Products
    AbbVie, Inc., United States
  • Jonathan  Amaya-Hodges
    Jonathan Amaya-Hodges Senior Principal Consultant
    Suttons Creek, Inc, United States
  • Brian  Baker
    Brian Baker Senior Director, Regulatory Affairs (CDx)
    Regeneron Pharmaceuticals, United States
  • Karthik  Balasubramanian, PhD, MS
    Karthik Balasubramanian, PhD, MS Director, Combination Products and Semisolids, Generic CPD
    Teva Pharmaceuticals, United States
  • Susan W. Neadle, MS, MSc
    Susan W. Neadle, MS, MSc Medical Device, Combination Products, Design Thinking, Process Excellence
    and Program Management Expert, United States
  • Kimberly  Trautman, MS
    Kimberly Trautman, MS Medical Device, IVD, and Combination Product Expert
    *, United States
  • John Barlow Weiner, JD
    John Barlow Weiner, JD Associate Director for Policy, Office of Combination Products, OCPP, OC
    FDA, United States
  • Megan  Doyle, JD, MPH
    Megan Doyle, JD, MPH Global Policy Lead, Digital Health, Diagnostics, Oncology, & Combination Product
    Amgen, United States
Load More

Digital Learning Catalog

DIA Learning: eLearning Soultions
Download